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INTRODUCTION:  Colorectal  cancer  most  often  presents  with  a  change  in bowel  habit,  weight  loss  or  with
bleeding  per  rectum.  Much  less  commonly,  colorectal  cancer  may  present  as  part  of a paraneoplas-
tic  syndrome.  Polymyositis  is a rare disease  most  often  considered  a complement-mediated  idiopathic
inﬂammatory  myopathy  manifested  by  proximal  muscle  weakness.  However,  polymyositis  may  also  be
part  of a paraneoplastic  syndrome  associated  with  an  underlying  malignancy.  The  relationship  between
polymyositis  and  malignancy  is  well  known,  but it has  been  suggested  that  tumours  of  the  large bowel
are  rarely  complicated  by myositis.
PRESENTATION  OF  CASE:  The  authors  describe  a  case  report of an 82-year-old  gentleman  with  a  presumed
musculoskeletal  or neurological  deﬁcit  who  was  subsequently  diagnosed  with  metastatic  colon  cancer  in
the setting  of progressive  fatigue  and muscle  weakness.  Concurrently,  we  review  the  current  literature
looking  at  the relationship  between  cancer  and  polymyositis.
DISCUSSION:  Colorectal  cancer  rarely  presents  with  symptoms  such  as  muscle  weakness,  however  it
is important  to be aware  of  the  possibility  of  an  underlying  malignancy  when  seeing  patients  with
symptoms  which  are  suggestive  of polymyositis.
CONCLUSION:  The  diagnosis  of polymyositis  in  the  elderly  population  should  raise  suspicion  of  an  under-
lying  malignancy.
© 2011 Surgical Associates Ltd. Elsevier Ltd. Open access under CC BY-NC-ND license.. Introduction
Colorectal cancer most often presents with a change in bowel
abit, weight loss or with bleeding per rectum. Much less com-
only, colorectal cancer may  present as part of a paraneoplastic
yndrome, deﬁned as, a symptom that is a consequence of the pres-
nce of cancer in the body but is not caused by the local effect of
eoplastic cells. Polymyositis is a rare disease most often consid-
red a complement-mediated idiopathic inﬂammatory myopathy
anifested by proximal muscle weakness. However, polymyositis
ay  also be manifested as part of a paraneoplastic process associ-
ted with an underlying malignancy.
. Presentation of case
A previously active 82-year-old man  presented to his general
ractitioner, complaining of bilateral leg weakness that had pro-
ressed gradually during the preceding 6 months. More recently
e had developed aches in his shoulders and proximal weakness
ffecting all four limbs. Clinical examination revealed symmetri-
al muscle weakness of the quadriceps and ﬂexor muscles of the
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Open access under CC BY-NC-ND licknee. The patient required assistance to stand from a seated posi-
tion and displayed a ‘waddling’ gait. He displayed no skin changes
suggestive of dermatomyositis. Initial blood tests were unremark-
able apart from a mildly elevated ESR of 28 mm/h. The patient was
initially diagnosed with polymyalgia rheumatica and commenced
on steroids. No improvement was  noted in the patient condition
over the next three months. Conversely, deterioration was  noted
in the symptoms and a rheumatology referral was  made.
Investigations by the Rheumatologist including an autoantibody
screen, which was positive for ANA and Anti-Ro. The Rheumatolo-
gist also made an urgent referral for a neurology opinion to rule out
a neurological cause to his symptoms. An MRI  thigh was reported
with “gross multi-compartmental fatty atrophy with widespread
inﬂammation, highly suspicious of a polymyositis”. Neurological tests,
including a muscle biopsy and neurophysiology, excluded motor
neurone disease or demyelination, but were described as “com-
plex changes, including both atrophic and hypertrophic muscle ﬁbres,
suggestive of polymyositis and likely to be part of a paraneoplastic
syndrome”.
It was  now considered highly likely that this patient’s weakness
had occurred as part of a paraneoplastic syndrome, despite him
being otherwise well, with a stable weight and no obvious symp-
toms that might localise a potential malignancy, and so a CT chest,
abdomen and pelvis was requested.
Despite the absence of bowel symptoms, CT images (Fig. 1)
revealed “signiﬁcant irregular descending colon thickening with
ense.
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3Fig. 1. Coronal CT scan identifying tumour in descending colon.
esenteric lymphadenopathy and hepatic metastases affecting
oth lobes of the liver”. A right sided renal mass was  also seen
n CT (Fig. 2) and was described as “a solid well-deﬁned rounded
ass” and considered as an associated second tumour. A ﬂexible
igmoidoscopy visualised a large tumour affecting the proximal
escending colon (Fig. 3), whilst histology conﬁrmed an invasive
oderately differentiated adenocarcinoma. The patient also under-
ent further blood tests and was found to be anaemic, with an
b = 10.6 g/dL, and had an elevated CEA (285).
Subsequently, a multidisciplinary team discussion concluded
hat an oncology referral for consideration of palliative chemother-
py would be the most appropriate plan. In view of the duration
nd persistence of his paraneoplastic myopathy, it was  decided that
hemotherapy was not likely to provide symptomatic relief or a sig-
iﬁcant gain in life expectancy; now thought to be months rather
han years. The patient continues to experience limiting proximal
uscle weakness and recently stated that he was shocked when heound out his symptoms were due to colorectal cancer, stating “I
ever even considered that my  symptoms could have been caused
y cancer”.
Fig. 3. Flexible sigmoidoscoFig. 2. Coronal CT scan identifying right sided renal mass.
3. Discussion
The term myopathy applies to both congenital and acquired
muscle diseases. Within the acquired group of diseases there is
distinction between dermatomyositis and polymyositis, which are
both inﬂammatory myopathies of unknown aetiology. Dermato-
myositis presents with characteristic skin changes accompanying,
or often preceding, muscle weakness, where as, polymyositis
involves muscle weakness in the absence of any skin changes.
The risk of cancer is increased in both myopathies, but there is a
greater risk with dermatomyositis when compared to those with
polymyositis.1,2
The association between myopathies, occurring as part of a
paraneoplastic syndrome, and cancer is well recognised, however,
epidemiological studies have been hindered by small case numbers,
referral bias and diagnostic inconsistencies. A population based
study conducted by Hill et al. described the link between myosi-
tis and malignancy, which concluded that patients suffering from
polymyositis were at an increased risk of cancer when compared
py image of tumour.
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Table 1
Population-based cohort studies on the link between myositis and malignancy.
Reference Frequency of cancer (% of patients) Relative risk
Dermatomyositis Polymyositis Dermatomyositis Polymyositis
Sigurgeirsson et al.4 61/392 (16%) 42/396 (11%) Female
4
Male Female Male
8
5 
t
l
r
c
m
t
r
c
b
t
t
t
r
f
p
m
h
t
a
e
O
t
n
d
c
p
o
w
d
a
h
w
t
o
4
a
b
i
c
i
f
r
c
c
d3.
Airio et al.5 31/203 (15%) 26/336 (8%) 3.
Chow et al.6 19/71 (27%) 12/175 (7%) 6.
o the general population. Table 1 summarises three other popu-
ation based cohort studies, from Scandinavia,4–6 investigating the
elationship between myositis and malignancy. All these studies
oncluded that there is an increased relative risk of malignancy in
yositis, but this is more pronounced in relation to dermatomyosi-
is as compared to polymyositis. These studies also showed that the
elationship was very rare below the age of 45.
Hill et al. concluded that the most common types of cancer asso-
iated with polymyositis were non-Hodgkin lymphoma, lung and
ladder cancer. It has been suggested elsewhere that other solid
umours, such as prostate and ovarian cancer, as well as haema-
ological malignancies can be associated with myositis. However,
his suggestion is not supported by deﬁnitive evidence and they
eported prevalence for various cancer types varies greatly in dif-
erent studies.7,8
More recent studies on this association have explored the patho-
hysiological mechanisms behind this relationship, ﬁnding that
yositis-speciﬁc antigens are over-expressed in cancer tissue.9 It is
ypothesized that increased myositis-speciﬁc antigens in a nascent
umour can lead to the formation of speciﬁc B-cells and T-cells
gainst the antigens, which is the cause of muscular inﬂammation.
In colorectal cancer the relationship with myopathy is
xtremely rare, particularly in the absence of cutaneous features.
urs is the ﬁrst case report of colon cancer, with polymyositis as
he presenting complaint of the patient, occurring as part of a para-
eoplastic syndrome. Our patient is unique as he had extensive
isease with metastases in the liver and the possibility of an asso-
iated renal tumour, which may  have also played a part in the
araneoplastic syndrome.
Some research has also looked into the use of surgical resection
f a tumour or chemotherapy in managing this problem, which
as discussed with regard to our patient. Theoretically, tumour-
riven autoimmunity may  help to explain any improvement in
 patient’s polymyositis following such interventions. In view of
is extensive metastatic disease, it was decided that our patient
as not to undergo radical surgery and the oncologist decided
hat chemotherapy would not provide sufﬁcient symptom relief
r increase in life expectancy.
. Conclusion
This case demonstrates the value of knowledge about associ-
ted paraneoplastic syndromes, as this may  help solve uncommon
ut serious diagnostic conundrums. Early diagnosis of malignancy
s critical in cases of polymyositis.10 Any hints we  as clinicians
an gain to aid a diagnosis are essential and therefore our study
dentiﬁes the importance in considering neoplasm as a differential
or patients presenting with symptoms of myopathy, as although
are, it can be the ﬁrst symptom at presentation and can provide a
linician with a vital clue to provide an earlier diagnosis of occult
ancer. We  suggest that patients over the age of 45, with a newly
iagnosed myositis, should be screened for occult cancer, including2.4 1.7 1.8
1.7
1.0
a thorough history and extensive examination, and investigations
including blood tests for haematological and biochemical screening
and assessment of tumour markers (CEA, CA-125, PSA, etc.).
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